What is the recommended dosing regimen of intravaginal metronidazole 0.75% gel for treating bacterial vaginosis in adult women of reproductive age, and is it safe to use during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Gel Dosing for Bacterial Vaginosis

For non-pregnant women with bacterial vaginosis, use metronidazole gel 0.75% one full applicator (5 grams) intravaginally once daily at bedtime for 5 days. 1

Standard Dosing Regimens

The FDA-approved dosing offers two options, though once-daily is preferred:

  • Once-daily regimen (preferred): One full applicator (5 grams containing 37.5 mg metronidazole) intravaginally at bedtime for 5 days 1
  • Twice-daily regimen (alternative): One full applicator (5 grams) intravaginally twice daily for 5 days 2

Once-daily dosing is equally effective as twice-daily dosing and improves patient compliance. 1 A randomized controlled trial of 514 women demonstrated equivalent cure rates at 1 month: 57% for once-daily versus 62% for twice-daily dosing, with no statistically significant difference 3

Critical Patient Counseling Points

Alcohol Avoidance

Patients must completely avoid all alcohol consumption during treatment and for 24 hours after the last dose to prevent disulfiram-like reactions (flushing, nausea, vomiting, tachycardia). 2, 1

Systemic Exposure Advantage

Metronidazole gel produces mean peak serum concentrations less than 2% of standard 500 mg oral doses, which minimizes systemic side effects including gastrointestinal disturbance and metallic taste while maintaining local efficacy. 2, 1

Safety in Pregnancy

First Trimester

Metronidazole is contraindicated in the first trimester of pregnancy. 1 If treatment is necessary during the first trimester, clindamycin vaginal cream 2% (one full applicator at bedtime for 7 days) is the only recommended option. 1

Second and Third Trimesters

After the first trimester, oral metronidazole 250 mg three times daily for 7 days is preferred over vaginal gel for pregnant women. 1 This systemic approach treats possible subclinical upper genital tract infections that may contribute to adverse pregnancy outcomes including preterm labor, premature rupture of membranes, and preterm birth. 2

Special Populations and Considerations

Metronidazole Allergy

Patients with true metronidazole allergy should NOT receive metronidazole gel vaginally—all metronidazole formulations are contraindicated. 1 Use clindamycin cream 2% (one full applicator at bedtime for 7 days) instead. 1

Patients with metronidazole intolerance (not true allergy) may use the vaginal gel due to minimal systemic absorption. 1

Partner Management

Routine treatment of male sex partners is NOT recommended. Multiple clinical trials demonstrate that partner treatment does not affect cure rates or reduce recurrence. 1

Follow-Up and Recurrence

  • No follow-up visit is necessary if symptoms resolve 2, 1
  • Recurrence is common (up to 50% within 1 year) 4
  • For recurrent BV, extended metronidazole gel therapy (0.75% for 10 days, followed by twice weekly for 3-6 months) may be considered 4

Common Clinical Pitfall

Do not use metronidazole gel for trichomoniasis treatment. Topical metronidazole is considerably less efficacious than oral preparations for trichomoniasis and should never be substituted. 1

References

Guideline

Metronidazole Gel Treatment for Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Characterization and Treatment of Recurrent Bacterial Vaginosis.

Journal of women's health (2002), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.